Effects of TCI Propofol on Maternal and Fetal Outcomes in VP-Shunt Surgery during the First Trimester of Pregnancy: A Narrative Review

Albinus Yunus Cobis, Iwan Abdul Rachman, Dewi Yulianti Bisri

Abstract


Neurosurgical procedures during pregnancy, particularly ventriculoperitoneal (VP) shunt placement in the first trimester, pose substantive challenges for anesthetic practice. Drug selection must protect both mother and fetus while accommodating pregnancy-related alterations in pharmacokinetics and pharmacodynamics. Propofol administered via Target Controlled Infusion (TCI) has become a preferred option in neuroanesthesia because it enables rapid reduction in intracranial pressure and precise titration. Reports from neuro-obstetric practice, including VP shunt operations, indicate that TCI propofol maintains stable anesthetic depth with fewer hemodynamic fluctuations than inhalational techniques. In pregnant patients, dosing is individualized using the Marsh model, typically targeting a plasma concentration of 2–4 µg/mL with an induction dose of 1–2 mg/kg. Although propofol readily crosses the placenta, contemporary data show fetal concentrations remain low and are rapidly cleared. Moreover, recent studies have not associated appropriately dosed, closely monitored propofol with increased rates of miscarriage, major congenital anomalies, or reduced live births. Accordingly, for first-trimester neuroanesthesia, TCI propofol is a safe and effective choice that supports maternal cerebral protection while minimizing fetal exposure. When combined with vigilant physiologic monitoring, titration to effect, and adherence to neuro-obstetric best practices, maternal and fetal outcomes are comparable to those achieved with inhalational anesthesia. These findings support the judicious adoption of TCI propofol for VP shunt surgery in early pregnancy, emphasizing individualized dosing and multidisciplinary perioperative coordination to optimize safety and efficacy. This review synthesizes current evidence and offers pragmatic dosing guidance for clinicians, aligned with contemporary neuroanesthesia and obstetric anesthesia standards

Keywords


Neuroanesthesia, Pregnancy, TCI propofol, Hydrocephalus, Maternal Outcomes

Full Text:

PDF

References


Devroe S, Van de Velde M, Rex S. General anesthesia for caesarean section. Curr Opin Anaesthesiol. 2015;28(3):240-246. doi: 10.1097/ACO.0000000000000185

Singh S, Sethi N. Neuroanesthesia and pregnancy: uncharted waters. Med J Armed Forces India. 2019;75(2):125–9. doi: 10.1016/j.mjafi.2018.10.001.

Pfizer Inc. Propofol injectable emulsion: use in specific populations – pregnancy [Internet]. New York: Pfizer Inc.; 2024 [cited 2025 Jul 11]. Available from: https://www.pfizermedicalinformation.com/propofol-injectable-emulsion/population-use

Dewan MC, Rattani A, Mekary R, Glancz LJ, Yunusa I, Baticulon RE, et al. Global hydrocephalus epidemiology and incidence: systematic review and meta-analysis. J Neurosurg. 2019;130(4):1065–79. doi: https://doi.org/10.3171/2017.10.JNS17439.

Discenza M, Papadakis JE, Little S, Madsen JR. Safety of pregnancy and delivery with shunted hydrocephalus. JAMA Netw Open. 2024;7(9):e2434688. doi:https://doi.org/10.1001/jamanetworkopen.2024.34688

Duci M, Pulvirenti R, Fascetti Leon F, Capolupo I, Veronese P, Gamba P, et al. Anesthesia for fetal operative procedures: a systematic review. Front Pain Res. 2022;3:935427. doi:https://doi.org/10.3389/fpain.2022.935427

Yildirim SA, Dogan L, Sarikaya ZT, Ulugol H, Gucyetmez B, Toraman F. Hypotension after anesthesia induction: Target-controlled infusion versus manual anesthesia induction of propofol. J Clin Med. 2023; 12(16):5280. doi: https://doi.org/10.3390/jcm12165280

Hassan WMNW, Nasir YM, Zaini RHM, Shukeri WFWM. Target-controlled infusion propofol versus sevoflurane anaesthesia for emergency traumatic brain surgery: Comparison of the outcomes. Malays J Med Sci. 2017;24(5):73–82. doi:10.21315/mjms2017.24.5.8

Lee S, Kang D, Song E, Yoo S, Jeong S. External validation of the modified Marsh and Schnider models for medium-chain triglyceride propofol in target-controlled infusion anesthesia. BMC Anesthesiol. 2024;24(1):70. doi: 10.1186/s12871-024-02461-5–

Absalom AR, Mason KP, editors. Total intravenous anesthesia and target controlled infusions: A comprehensive global anthology. Cham: Springer. 2017. 83778 1. doi: 10.1007/978 3 319 83779 8.

Melaku L. Physiological changes in the pregnancy and anesthetic implication during labor, delivery, and postpartum. Open Anesthesia J, 2022; 16: e258964582207130. doi: http://dx.doi.org/10.2174/25896458-v16-e2207130

Pariente G, Leibson T, Carls A, Adams-Webber T, Ito S, Koren G. Pregnancy-associated changes in pharmacokinetics: A systematic review. PLoS Med. 2016;13(11):e1002160. Published 2016 Nov 1. doi:https://doi.org/10.1371/journal.pmed.1002160

Chen P-N, Lu I-C, Huang T-W, Chen P-C, Lin W-C, Lu W-L, Tse J. Application of propofol target-controlled infusion for optimized hemodynamic status in ESRD patients receiving arteriovenous access surgery: A randomized controlled trial. Medicina. 2022; 58(9):1203. doi: https://doi.org/10.3390/medicina58091203

Hu L, Pan J, Zhang S, Yu J, He K, Shu S, et al. Propofol in combination with remifentanil for cesarean section: placental transfer and effect on mothers and newborns. Taiwan J Obstet Gynecol. 2017;56(4):521–526. doi: 10.1016/j.tjog.2016.09.010.

Ngamprasertwong P, Dong M, Niu J, Venkatasubramanian R, Vinks AA, Sadhasivam S, et al. Propofol pharmacokinetics and estimation of fetal propofol exposure during mid gestational fetal surgery: a maternal–fetal sheep model. PLoS One. 2016;11(1):e0146563. doi: 10.1371/journal.pone.0146563

Tumukunde J, Lomangisi D, Ocen D, Kintu A, Joseph E, Kwizera A, et al. Effects of propofol versus thiopental on Apgar scores in newborns and peri operative outcomes of women undergoing emergency cesarean section: a randomized clinical trial. BMC Anesthesiol. 2015;15:63. doi:10.1186/s12871-015-0044-6.

Lee SW, Lim C, Kim JY, Park S, Lee YJ, Oh KJ, et al. Anaesthesia for non obstetric surgery during pregnancy: maternal and fetal outcomes in a large cohort. Br J Anaesth. 2022;129(5):e320–e327. doi: 10.1016/j.bja.2022.07.021.

Hassan WMNW, Nasir YM, Zaini RHM, Shukeri WFWM, Wan Mohd Nazaruddin W, Norazman MR, et al. Target-controlled infusion propofol versus sevoflurane anesthesia for emergency traumatic brain surgery: comparison of the outcomes. Malays J Med Sci. 2017;24(5):73–82. doi: 10.21315/mjms2017.24.5.8

Rozec B, Floch H, Berlivet P, Michel P, Blanloeil Y. Propofol versus thiopental by target controlled infusion in patients undergoing craniotomy. Minerva Anestesiol. 2014;80(7):761-8.

Upadya M, Saneesh PJ. Anaesthesia for non-obstetric surgery during pregnancy. Indian J Anaesth. 2016;60(4):234–41. doi: https://doi.org/10.4103/0019-5049.179445.




DOI: https://doi.org/10.24244/jni.v15i2.701

Refbacks

  • There are currently no refbacks.


 

JNIis licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License